177 related articles for article (PubMed ID: 30683264)
21. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS).
Eltoum IA; Roberson J
Cancer; 2007 Feb; 111(1):34-40. PubMed ID: 17262799
[TBL] [Abstract][Full Text] [Related]
22. [What does HPV vaccination mean for gynecologic cancer screening?].
Petry KU
Hautarzt; 2007 Jun; 58(6):501-6. PubMed ID: 17497103
[TBL] [Abstract][Full Text] [Related]
23. HPV vaccination: vaccine acceptance, side effects and screening intentions.
Paul-Ebhohimhen V; Huc S; Tissington H; Oates K; Stark C
Community Pract; 2010 Jun; 83(6):30-3. PubMed ID: 20586376
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study.
Agorastos T; Chatzistamatiou K; Zafrakas M; Siamanta V; Katsamagkas T; Constantinidis TC; Lampropoulos AF;
Eur J Cancer Prev; 2014 Sep; 23(5):425-31. PubMed ID: 24977385
[TBL] [Abstract][Full Text] [Related]
25. Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists.
; Collins Y; Einstein MH; Gostout BS; Herzog TJ; Massad LS; Rader JS; Wright J
Gynecol Oncol; 2006 Sep; 102(3):552-62. PubMed ID: 16979432
[TBL] [Abstract][Full Text] [Related]
26. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
Perkins RB; Anderson BL; Gorin SS; Schulkin JA
Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
[TBL] [Abstract][Full Text] [Related]
27. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
[TBL] [Abstract][Full Text] [Related]
28. [Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].
Monsonego J
Presse Med; 2007 Apr; 36(4 Pt 2):640-66. PubMed ID: 17350792
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.
Reynales-Shigematsu LM; Rodrigues ER; Lazcano-Ponce E
Arch Med Res; 2009 Aug; 40(6):503-13. PubMed ID: 19853192
[TBL] [Abstract][Full Text] [Related]
31. The incidence of genital warts in Australian women prior to the national vaccination program.
Brotherton JM; Heywood A; Heley S
Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
[TBL] [Abstract][Full Text] [Related]
32. A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines.
Guerrero AM; Genuino AJ; Santillan M; Praditsitthikorn N; Chantarastapornchit V; Teerawattananon Y; Alejandria M; Toral JA
BMC Public Health; 2015 Jul; 15():730. PubMed ID: 26223975
[TBL] [Abstract][Full Text] [Related]
33. [HPV infection in etiology of uterine cervix cancer].
Olejek A
Ginekol Pol; 2008 Feb; 79(2):126-32. PubMed ID: 18510092
[TBL] [Abstract][Full Text] [Related]
34. Screening and early diagnosis of gynecologic cancers.
Warner EA; Parsons AK
Med Clin North Am; 1996 Jan; 80(1):45-61. PubMed ID: 8569300
[TBL] [Abstract][Full Text] [Related]
35. From the monovalent to the nine-valent HPV vaccine.
Pils S; Joura EA
Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
[TBL] [Abstract][Full Text] [Related]
36. The challenge of eliminating cervical cancer in the United States: a story of politics, prudishness, and prevention.
Fisher JW; Brundage SI
Women Health; 2009; 49(2-3):246-61. PubMed ID: 19533513
[TBL] [Abstract][Full Text] [Related]
37. Integrating novel primary- and secondary-prevention strategies: the next challenge for cervical cancer control.
Mayrand MH; Franco EL
Future Oncol; 2010 Nov; 6(11):1725-33. PubMed ID: 21142659
[TBL] [Abstract][Full Text] [Related]
38. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
39. Cervical cancer prevention practices through screening and vaccination: A cross-sectional study among Hong Kong Chinese women.
Wang LD; Lam WW; Fielding R
Gynecol Oncol; 2015 Aug; 138(2):311-6. PubMed ID: 26022528
[TBL] [Abstract][Full Text] [Related]
40. The impact of HPV vaccination on future cervical screening: a simulation study of two birth cohorts in Denmark.
Hestbech MS; Lynge E; Kragstrup J; Siersma V; Vazquez-Prada Baillet M; Brodersen J
BMJ Open; 2015 Aug; 5(8):e007921. PubMed ID: 26275901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
